Patient Capital Management 13F, Q4 2025
Samantha McLemore · quarter ending 31 December 2025 · filed 13 February 2026 · SEC CIK 1854794
Common stock only: shares the fund reported owning at the quarter end, valued as filed.
Largest positions, Q4 2025
The 25 largest of 40 positions. Weights are against the whole filed book. Changes are in shares held, against the Q3 2025 filing.
| Company | Ticker | Value | % of book | vs Q3 2025 |
|---|---|---|---|---|
| ALPHABET INC | GOOGL | $182.05M | 7.0% | -5% shares |
| CITIGROUP INC | C | $150.74M | 5.8% | unchanged |
| AMAZON COM INC | AMZN | $129.85M | 5.0% | unchanged |
| ROYALTY PHARMA PLC | $128.81M | 5.0% | +7% shares | |
| QXO INC | QXO | $124.78M | 4.8% | unchanged |
| UNITEDHEALTH GROUP INC | UNH | $121.58M | 4.7% | unchanged |
| NVIDIA CORPORATION | NVDA | $119.14M | 4.6% | unchanged |
| NORWEGIAN CRUISE LINE HLDG L | $118.48M | 4.6% | +16% shares | |
| BIOGEN INC | BIIB | $101.43M | 3.9% | +45% shares |
| CVS HEALTH CORP | CVS | $97.73M | 3.8% | unchanged |
| META PLATFORMS INC | META | $94.45M | 3.6% | unchanged |
| IAC INC | PPLI | $92.83M | 3.6% | +13% shares |
| ENERGY TRANSFER L P | ET | $86.95M | 3.4% | +8% shares |
| PRECIGEN INC | PGEN | $78.06M | 3.0% | -29% shares |
| ILLUMINA INC | ILMN | $75.52M | 2.9% | unchanged |
| UNITED AIRLS HLDGS INC | UAL | $73.14M | 2.8% | unchanged |
| SEADRILL LTD | $71.06M | 2.7% | -8% shares | |
| CROCS INC | CROX | $64.89M | 2.5% | +29% shares |
| GENERAL MTRS CO | GM | $62.75M | 2.4% | -18% shares |
| FIDELITY WISE ORIGIN BITCOIN | FBTC | $59.59M | 2.3% | +26% shares |
| ONEMAIN HLDGS INC | OMF | $55.72M | 2.1% | -12% shares |
| MATTEL INC | MAT | $55.44M | 2.1% | +33% shares |
| UBS GROUP AG | $54.99M | 2.1% | -21% shares | |
| CHIME FINL INC | CHYM | $51.22M | 2.0% | new |
| EXPEDIA GROUP INC | EXPE | $49.94M | 1.9% | -31% shares |
What changed since Q3 2025
Against the Q3 2025 filing, Patient Capital Management opened 2 new positions, added to 11, trimmed 12, left 15 unchanged and exited 3. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.
Other quarters
Source: SEC Form 13F-HR, accession 0001854794-26-000003, filed by Patient Capital Management, LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.